Guoke Hengtai Accumulated Non-Material Litigation and Arbitration New Additions of 25 Cases with Progress Involving Amount Exceeding 138 Million Yuan

robot
Abstract generation in progress

Log in to Sina Finance App and search for [Disclosure of Information] to see more evaluation levels.

Guoke Hengtai (Beijing) Medical Technology Co., Ltd. (Stock code: 301370, Stock abbreviation: Guoke Hengtai) announced on March 18th the latest progress on the company’s cumulative non-material lawsuits and arbitration cases. The announcement shows that as of the disclosure date, the company and its subsidiaries have new developments in 25 cases, involving a total amount of approximately 138 million yuan. Among them, Guoke Hengtai Maodong’s contract dispute with Jumei has applied for a change in the lawsuit request.

The announcement states that the contract dispute case between Guoke Hengtai Maodong and Jumei (Shanghai) Medical Equipment Co., Ltd. has submitted an application to the Shanghai Changning District People’s Court to change the lawsuit request, requesting to withdraw part of the lawsuit. The revised request is for Jumei to return tool deposits and prepayments totaling 5.8973 million yuan, and to bear the litigation costs of this case.

In addition to the above cases, 24 other non-material lawsuits and arbitration cases previously disclosed have made new progress, involving an amount of 132.1983 million yuan. Among them, 19 cases where the company and its subsidiaries are plaintiffs involve 126.1996 million yuan, with specific progress including 5 cases completed, 5 cases appealed, 2 enforcement applications, 3 first-instance judgments issued, 2 cases withdrawn, and 2 final rulings issued; 5 cases where the company is defendant involve 5.9987 million yuan, with 3 cases completed and 2 settled through reconciliation.

The announcement also discloses the current litigation and arbitration cases where the amount exceeds 10 million yuan, detailed as follows:

No. Plaintiff/Applicant Defendant/Respondent Cause of Action Litigation/Arbitration Institution Amount (10,000 yuan) Stage Filing/Acceptance Date
1 Guoke Hengtai Maodong (Beijing) Medical Technology Co., Ltd. Jiemai (Shanghai) Medical International Trade Co., Ltd., Jumei (Shanghai) Medical Equipment Co., Ltd. Contract Dispute Shanghai First Intermediate People’s Court 1036.325 First-instance judgment issued, plaintiff appealed December 6, 2024
2 Guoke Hengtai (Beijing) Medical Technology Co., Ltd. Fujian Baishiwei Medical Polymer Co., Ltd., Baishiwei (Changting) Medical Equipment Co., Ltd., Chen Yongxi Contract Dispute Beijing Daxing District People’s Court 111.343 First-instance judgment issued, plaintiff appealed April 29, 2025
3 Guoke Hengtai (Beijing) Medical Technology Co., Ltd. Suzhou Xinrong Borte Medical Equipment Co., Ltd. Contract Dispute Shanghai Arbitration Commission 1358.13 Filed but not yet heard August 4, 2025
4 Guoke Hengtai (Beijing) Medical Technology Co., Ltd. Xi’an Damai Intelligent Technology Co., Ltd. Contract Dispute Beijing Arbitration Commission 174.623 Heard but not yet judged August 6, 2025
Total 2680.421

Additionally, the company states that as of the disclosure date of this announcement, aside from the cases already disclosed, there are no other lawsuits or arbitration matters that need to be disclosed but have not been disclosed. The company will actively respond to and properly handle the involved cases. Since some cases have not yet gone to court or been concluded, their impact on the company’s current or future profits is uncertain. The company will follow accounting standards and actual circumstances for appropriate accounting treatment, closely monitor case developments, and fulfill disclosure obligations in a timely manner.

Click to view the original announcement >>

Disclaimer: The market carries risks; investment should be cautious. This article is automatically published by an AI model based on third-party databases and does not represent Sina Finance’s views. All information in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for any discrepancies. If you have questions, please contact biz@staff.sina.com.cn.

Massive information, precise interpretation, all on Sina Finance App.

Editor: Xiao Lang Kuai Bao

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin